Stereotactic body radiation therapy in unresectable stage III non-small cell lung cancer: a systematic review
Lung cancer is the leading cause of cancer death worldwide with an estimated 1.8 million deaths per year [1], mainly represented by non-small cell lung cancers (NSCLC). Approximately one third of patients is diagnosed with locally advanced disease (LA) [2]. Many of these patients have unresectable disease or are medically inoperable. The definition of unresectable stage III NSCLC varies and may include technically resectable disease [3]. There is consensus that the overall survival (OS) of most patients is similar whether treated locally with surgery or radiotherapy.
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Beno ît ALLIGNET, Dirk DE RUYSSCHER, Isabelle MARTEL-LAFAY, Waisse WAISSI Tags: Systematic or Meta-analysis Studies Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Radiation Therapy | Study